Raras
Buscar doenças, sintomas, genes...
Poroqueratose
ORPHA:79358CID-11 · ED52DOENÇA RARA

Proliferação clonal de queratinócitos anormais caracterizada pelo desenvolvimento de manchas cutâneas atróficas localizadas ou múltiplas, cercadas por um anel ceratótico anular denominado lamela cornóide.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Proliferação clonal de queratinócitos anormais caracterizada pelo desenvolvimento de manchas cutâneas atróficas localizadas ou múltiplas, cercadas por um anel ceratótico anular denominado lamela cornóide.

Publicações científicas
1.357 artigos
Último publicado: 2026 Mar
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
11 sintomas
💪
Músculos
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

Prurido
Carcinoma de células escamosas
Fotossensibilidade cutânea
Poroceratose
Distrofia ungueal
Pápula
19sintomas
Sem dados (19)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 19 características clínicas mais associadas, ordenadas por frequência.

PruridoPruritus
Carcinoma de células escamosasSquamous cell carcinoma
Fotossensibilidade cutâneaCutaneous photosensitivity
PoroceratosePorokeratosis
Distrofia unguealNail dystrophy

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.357PubMed
Últimos 10 anos200publicações
Pico202560 papers
Linha do tempo
2026Hoje · 2026🧪 2000Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

5 genes identificados com associação a esta condição.

PMVKPhosphomevalonate kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the reversible ATP-dependent phosphorylation of mevalonate 5-phosphate to produce mevalonate diphosphate and ADP, a key step in the mevalonic acid mediated biosynthesis of isopentenyl diphosphate and other polyisoprenoid metabolites

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Porokeratosis 1, multiple types

A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
111.8 TPM
Esôfago - Mucosa
99.8 TPM
Skin Not Sun Exposed Suprapubic
98.9 TPM
Skin Sun Exposed Lower leg
98.0 TPM
Linfócitos
96.7 TPM
OUTRAS DOENÇAS (2)
porokeratosis 1, Mibelli typeporokeratosis of Mibelli
HGNC:9141UniProt:Q15126
SLC17A9Voltage-gated purine nucleotide uniporter SLC17A9Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Voltage-gated ATP nucleotide uniporter that can also transport the purine nucleotides ADP and GTP. Uses the membrane potential as the driving force to control ATP accumulation in lysosomes and secretory vesicles (PubMed:18375752, PubMed:23467297). By controlling ATP storage in lysosomes, regulates ATP-dependent proteins of these organelles (PubMed:35269509). Also indirectly regulates the exocytosis of ATP through its import into lysosomes in astrocytes and secretory vesicles such as adrenal chro

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, chromaffin granule membraneCytoplasmic vesicle, secretory vesicle membraneLysosome membrane

MECANISMO DE DOENÇA

Porokeratosis 8, disseminated superficial actinic type

A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Disseminated superficial actinic porokeratosis (DSAP) is the most common subtype. It is characterized by multiple small, annular, anhidrotic, keratotic lesions that are located predominantly on sun-exposed areas of the skin, such as the face, neck, and distal limbs. The lesions typically begin to develop in adolescence and reach near-complete penetrance by the third or fourth decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
96.5 TPM
Linfócitos
64.5 TPM
Baço
41.6 TPM
Fibroblastos
31.9 TPM
Pulmão
15.8 TPM
OUTRAS DOENÇAS (2)
porokeratosis 8, disseminated superficial actinic typedisseminated superficial actinic porokeratosis
HGNC:16192UniProt:Q9BYT1
MVKMevalonate kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the phosphorylation of mevalonate to mevalonate 5-phosphate, a key step in isoprenoid and cholesterol biosynthesis (PubMed:11278915, PubMed:18302342, PubMed:9325256, PubMed:9392419)

LOCALIZAÇÃO

CytoplasmPeroxisome

VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Mevalonic aciduria

Accumulation of mevalonic acid which causes a variety of symptoms such as psychomotor retardation, dysmorphic features, cataracts, hepatosplenomegaly, lymphadenopathy, anemia, hypotonia, myopathy, and ataxia.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
41.6 TPM
Esôfago - Mucosa
40.7 TPM
Skin Sun Exposed Lower leg
34.1 TPM
Rim - Medula
33.4 TPM
Skin Not Sun Exposed Suprapubic
32.7 TPM
OUTRAS DOENÇAS (5)
mevalonic aciduriaporokeratosis 3, disseminated superficial actinic typehyperimmunoglobulinemia D with periodic feverporokeratosis of Mibelli
HGNC:7530UniProt:Q03426
FDPSFarnesyl pyrophosphate synthaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key enzyme in isoprenoid biosynthesis which catalyzes the formation of farnesyl diphosphate (FPP), a precursor for several classes of essential metabolites including sterols, dolichols, carotenoids, and ubiquinones. FPP also serves as substrate for protein farnesylation and geranylgeranylation. Catalyzes the sequential condensation of isopentenyl pyrophosphate with the allylic pyrophosphates, dimethylallyl pyrophosphate, and then with the resultant geranylpyrophosphate to the ultimate product fa

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (2)
Lanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Porokeratosis 9, multiple types

A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
239.2 TPM
Fibroblastos
108.2 TPM
Esôfago - Mucosa
99.1 TPM
Pulmão
90.6 TPM
Skin Sun Exposed Lower leg
83.5 TPM
OUTRAS DOENÇAS (2)
porokeratosis 9, multiple typesdisseminated superficial actinic porokeratosis
HGNC:3631UniProt:P14324
MVDDiphosphomevalonate decarboxylaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the ATP dependent decarboxylation of (R)-5-diphosphomevalonate to form isopentenyl diphosphate (IPP). Functions in the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP), a key precursor for the biosynthesis of isoprenoids and sterol synthesis

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (3)
Synthesis of dolichyl-phosphateLanosterol biosynthesisActivation of gene expression by SREBF (SREBP)
MECANISMO DE DOENÇA

Porokeratosis 7, multiple types

A form of porokeratosis, a disorder of faulty keratinization characterized by one or more atrophic patches surrounded by a distinctive hyperkeratotic ridgelike border called the cornoid lamella. The keratotic lesions can progress to overt cutaneous neoplasms, typically squamous cell carcinomas. Multiple clinical variants of porokeratosis are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis. Different clinical presentations can be observed among members of the same family. Individuals expressing more than one variant have also been reported.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
66.6 TPM
Linfócitos
65.2 TPM
Cérebro - Hemisfério cerebelar
63.6 TPM
Esôfago - Mucosa
63.3 TPM
Testículo
63.0 TPM
OUTRAS DOENÇAS (2)
porokeratosis 7, multiple typesdisseminated superficial actinic porokeratosis
HGNC:7529UniProt:P53602

Variantes genéticas (ClinVar)

297 variantes patogênicas registradas no ClinVar.

🧬 MVD: GRCh37/hg19 16q24.2-24.3(chr16:87640702-89570635)x1 ()
🧬 MVD: NM_002461.3(MVD):c.1014-1G>T ()
🧬 MVD: GRCh37/hg19 16q11.2-24.3(chr16:46432879-90294753)x3 ()
🧬 MVD: GRCh37/hg19 16q24.2-24.3(chr16:87794842-89460290)x1 ()
🧬 MVD: Single allele ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 632 variantes classificadas pelo ClinVar.

95
284
253
Patogênica (15.0%)
VUS (44.9%)
Benigna (40.0%)
VARIANTES MAIS SIGNIFICATIVAS
MVK: NM_000431.4(MVK):c.678-1G>A [Likely pathogenic]
MVK: NM_000431.4(MVK):c.527+2T>G [Likely pathogenic]
MVK: NM_000431.4(MVK):c.1A>G (p.Met1Val) [Pathogenic]
MVK: NM_000431.4(MVK):c.528G>A (p.Arg176=) [Uncertain significance]
MVK: NM_000431.4(MVK):c.134G>A (p.Ser45Asn) [Uncertain significance]

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 11
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Poroqueratose

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

2 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
477 papers (10 anos)
#1

Systematized Linear Porokeratosis With Palmoplantar and Nail Involvement: A Rare Presentation.

Cureus2026 Feb

Porokeratosis encompasses a group of genetically and clinically heterogenous dermatoses characterized by abnormal epidermal keratinization, with the cornoid lamella being the hallmark histological feature. Linear porokeratosis, a rare variant of porokeratosis, typically manifests early in life, with lesions that follow the lines of Blaschko and carry the highest risk of malignancy transformation. Here, we present a case of systematized linear porokeratosis in a 48-year-old male with childhood onset, notable for the rare co-existence of palmoplantar and nail involvement. This report emphasizes the importance of long-term surveillance in patients with linear porokeratosis due to its malignant potential.

#2

Successful Treatment of Linear Porokeratosis with Ivarmacitinib in an Adolescent: A Case Report.

Clinical, cosmetic and investigational dermatology2026

Porokeratosis is a rare cutaneous disorder of keratinization, and its linear variant typically follows the lines of Blaschko. We report a case of a 15-year-old female patient with a 3-year history of a linear eruption on her right waist and thigh, accompanied by severe pruritus. Previous interventions, including topical corticosteroids, antihistamines, and oral prednisone, had failed to produce clinical improvement. The diagnosis of linear porokeratosis was confirmed after histopathological examination revealed the characteristic cornoid lamella. The patient was prescribed ivarmacitinib at a dose of 4 mg once daily. At the 3-month follow-up, the patient reported a significant reduction in pruritus, and clinical examination showed marked flattening of the papules, with no adverse events reported. Ivarmacitinib is a highly selective JAK1 inhibitor, and JAK1 plays a crucial role in the pathogenesis of inflammatory diseases. Ivarmacitinib was successfully utilized for the first time in the treatment of an adolescent patient with linear porokeratosis. Although the precise mechanism by which ivarmacitinib addresses linear porokeratosis has yet to be definitively elucidated, this case provides clinicians with a novel perspective and an additional option regarding pharmacological selection and therapeutic strategies.

#3

New Eruption of Bullous Pemphigoid Within Disseminated Superficial Porokeratosis Lesions: A Rare Case Report.

The Australasian journal of dermatology2026 Mar 05

In 2024, a 75-year-old Chinese man presented with a complex dermatological case involving features of both disseminated superficial porokeratosis (DSP) and bullous pemphigoid (BP). The patient exhibited a long-standing history of pruritic annular brownish plaques with hyperkeratotic borders, alongside recent blistering eruptions on his hands, feet and trunk. Diagnostic investigations revealed distinct histopathological and immunological markers characteristic of both conditions. Treatment with intravenous methylprednisolone, topical corticosteroids and tretinoin cream led to rapid improvement of BP lesions but also DSP plaques, culminating in complete resolution without new eruptions during corticosteroid tapering. Dermoscopic examination unveiled unique features, including the 'double-track sign', dilated capillaries and a central yellowish translucent area with haemorrhagic crusts, underscoring the diagnostic utility of dermoscopy in elucidating this rare co-presentation. This case highlights the diagnostic challenges and therapeutic considerations in managing concurrent DSP and BP, shedding light on potential exacerbating factors and treatment outcomes deserving further exploration in dermatological research.

#4

Disseminated superficial porokeratosis with dermal amyloid deposits: A case report and review of the literature.

The Journal of international medical research2026 Feb

Disseminated superficial porokeratosis with dermal amyloid deposits is exceptionally rare, with only 12 documented cases worldwide. The pathogenesis involves keratinocyte degeneration, resulting in amyloid deposition. A 76-year-old Chinese male presented with a 10-year history of multiple annular brown pruritic macules on the extremities and trunk, along with dense pruritic papules on the bilateral anterior tibial regions. Histopathological examination revealed cornoid lamella, dyskeratotic cells, and dermal amyloid deposits. Treatment with topical corticosteroids, 3% boric acid, and oral acitretin improved pruritus and pigmentation over 4 months; however, lesions recurred after discontinuation. Concomitant hyperuricemia (523 μmol/L) suggests a potential novel role of purine metabolism in amyloidogenesis, an association that has not been previously reported.

#5

Identification of two novel MVD mutations and one novel FDPS mutation in Chinese patients with porokeratosis.

Frontiers in medicine2026

Porokeratosis (PK) is an autosomal dominant inherited disorder characterized by abnormal epidermal keratinization, primarily resulting from mutations in four genes associated with the mevalonate pathway: mevalonate decarboxylase (MVD), mevalonate kinase (MVK), phosphomevalonate kinase (PMVK), and farnesyl diphosphate synthase (FDPS). The purpose of this study was to identify the causative mutations in seven sporadic cases of PK. Clinical data and blood samples were collected from these seven sporadic cases. To identify pathogenic gene mutations in the patients, both whole-exome and Sanger sequencing were conducted. Bioinformatics resources such as PROVEAN, SIFT, PolyPhen-2, and Mutation Taster were employed to assess the pathogenicity of the identified mutations. This study included seven sporadic cases of PK, comprising two cases of disseminated superficial actinic porokeratosis (DSAP), and five cases of disseminated superficial porokeratosis (DSP). We identified a total of five heterozygous mutations, including two novel MVD mutations (c.1122 + 1G > A, c.576G > T), one novel FDPS mutation (c.986A > C), and two MVD mutations that have been reported previously (c.1A > G and c.746 T > C). In conjunction with our previous study, we identified a total of six patients with the MVD c.746 T > C mutation from Jiangxi province, China, representing 50% of the total MVD mutation cases (12 in total). This research has expanded the database of mevalonate pathway genes associated with PK, thereby improving our comprehension of the fundamental mechanisms involved.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.202 artigos no totalmostrando 197

2026

Systematized Linear Porokeratosis With Palmoplantar and Nail Involvement: A Rare Presentation.

Cureus
2026

Successful Treatment of Linear Porokeratosis with Ivarmacitinib in an Adolescent: A Case Report.

Clinical, cosmetic and investigational dermatology
2025

A Case of Porokeratosis Ptychotropica Treated with Cryotherapy.

Acta dermatovenerologica Croatica : ADC
2026

A 12-year expanding pink plaque on the chest.

JAAD case reports
2026

New Eruption of Bullous Pemphigoid Within Disseminated Superficial Porokeratosis Lesions: A Rare Case Report.

The Australasian journal of dermatology
2026

Disseminated superficial porokeratosis with dermal amyloid deposits: A case report and review of the literature.

The Journal of international medical research
2025

Exploring MPM-FLIM for diagnostics of porokeratosis - a pilot study ex vivo.

Biomedical optics express
2026

Identification of two novel MVD mutations and one novel FDPS mutation in Chinese patients with porokeratosis.

Frontiers in medicine
2025

Porokeratosis palmaris et plantaris disseminata: broadening dermoscopic insights in a rare entity.

Dermatology online journal
2026

Solitary Genitogluteal Porokeratosis With Multiple Cornoid Lamellae: A Phenotypic Bridge Between Mibelli and Penoscrotal Variants.

The Journal of dermatology
2026

Double Trouble in Porokeratosis: Exploring Coexistent Porokeratosis Ptychotropica and Mibelli in Four Patients.

Indian dermatology online journal
2026

Topical Statins in the Treatment of Porokeratosis: A Systematic Review.

Clinical and experimental dermatology
2026

Keratosis Lichenoides Chronica: Disease Associations and Treatment Response in Adult and Pediatric Populations.

Journal of cutaneous medicine and surgery
2026

Diamond necklace appearance on ultraviolet fluorescence dermoscopy in porokeratosis.

QJM : monthly journal of the Association of Physicians
2026

Generalized Linear Porokeratosis Treated With Ixekizumab.

The Journal of dermatology
2026

Disseminated Superficial Actinic Porokeratosis in a Woman With Metastatic Pancreatic Cancer During Chemotherapy With Capecitabine and Nab-Paclitaxel.

The Australasian journal of dermatology
2025

Eruptive disseminated porokeratosis with diagnostic dermoscopic clues.

JAAD case reports
2025

Grenz Ray Therapy for Porokeratosis Ptychotropica: A Case Report.

Case reports in dermatology
2025

Long-term disease control of disseminated superficial actinic porokeratosis (DSAP) with simvastatin 2%/ cholesterol 2% cream.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.

Pharmaceuticals (Basel, Switzerland)
2025

PMVK-related disseminated superficial and scrotal porokeratosis.

Indian journal of dermatology, venereology and leprology
2026

Germline and somatic second-hit changes in porokeratosis: comprehensive variant spectrum and genotype-phenotype correlation analysis.

The British journal of dermatology
2025

From a Gene Mutation to Pathology and Targeted Therapy in a Patient with Therapy-resistant Porokeratosis.

Acta dermato-venereologica
2025

High-Frequency Electrocautery and Photodynamic Therapy for Porokeratosis Ptychotropica.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2025

The RANK-RANKL-OPG axis in dermatological malignancies: A systematic review.

International immunopharmacology
2025

Unilateral Blaschkoid Porokeratosis of the Face.

Indian dermatology online journal
2025

Porokeratosis ptychotropica mimicking a herpes simplex virus infection.

JAAD case reports
2025

Systematized Linear Porokeratosis, with Underlying Mevalonate Kinase Mutation, Treated with a Combination of Radiosurgery and Oral Acitretin.

Indian dermatology online journal
2026

[Porokeratosis ptychotropica with mycotic superinfection in a 68-year-old man].

Dermatologie (Heidelberg, Germany)
2025

Treatment of Porokeratosis Ptychotropica With Upadacitinib.

JAMA dermatology
2025

Temporary improvement of porokeratotic inflammatory linear verrucous epidermal nevus with fractionated CO2 laser resurfacing.

Dermatology online journal
2025

Topical Lovastatin/Cholesterol as a Potential Field-Directed Therapy for Disseminated Superficial Actinic Porokeratosis: A Case Report.

Cureus
2025

A case report of eruptive pruritic papular porokeratosis with atopic dermatitis treated with upadacitinib: a novel therapeutic perspective.

Frontiers in medicine
2025

Eruptive Pruritic Papular Porokeratosis in a 77-Year-Old Male: A Rare Case.

Cureus
2025

Porokeratosis ptychotropica: Diagnostic insights into a rare dermatosis.

JAAD case reports
2026

Abrocitinib in the Treatment of Eruptive Pruritic Papular Porokeratosis: A Case Report.

International journal of dermatology
2025

Porokeratosis Ptychotropica: A Clinical Note from Vietnam.

Oman medical journal
2025

First case of penile porokeratosis from Nepal: a case report.

Annals of medicine and surgery (2012)
2025

Ultraviolet-Induced Fluorescence Dermoscopy: Game Changers.

The Journal of clinical and aesthetic dermatology
2026

[Multiple squamous cell carcinomas arising in linear porokeratosis].

Dermatologie (Heidelberg, Germany)
2026

Multiple Verrucous Nodules and Masses in an Adolescent Boy With Porokeratoma: A Case Report and Literature Review.

Pediatric dermatology
2025

A Case of Disseminated Bullous Superficial Porokeratosis.

International journal of dermatology
2025

Ultraviolet-Induced Fluorescence Dermoscopy of Porokeratosis.

Indian dermatology online journal
2025

Lichen Sclerosus et Atrophicus, Porokeratosis, and Vitiligo: First Report of Coexistence of the Three Entities in a Child.

Indian dermatology online journal
2025

Expanding the Clinical Spectrum of Porokeratosis Ptychotropica.

Cureus
2025

Tense Bullous Eruptions Arising in Porokeratosis: A Quiz.

Acta dermato-venereologica
2025

Eruptive Disseminated Porokeratosis Induced by PEB Chemotherapy: A Case Report.

International journal of dermatology
2025

Case Report: Rapid and Effective Treatment of Porokeratosis With Fractional CO2 Laser Combined With Topical 2% Cholesterol/Lovastatin Ointment.

Journal of cosmetic dermatology
2025

All pain, no gain: porokeratosis ptychotropica remains a therapeutic challenge.

Clinical and experimental dermatology
2025

CHILD syndrome combined linear porokeratosis in a patient with a good response to the topical lovastatin/cholesterol ointment.

The Journal of dermatological treatment
2026

A case of porokeratosis ptychotropica mimicking condyloma acuminatum.

Journal of the European Academy of Dermatology and Venereology : JEADV
2025

Safety and efficacy of topical simvastatin plus cholesterol cream versus topical simvastatin cream alone for porokeratosis ptychotropica: A randomized, single-blind, split-body, placebo-controlled, investigator-initiated trial.

Journal of the American Academy of Dermatology
2025

An Unusual Presentation of Verrucous Porokeratosis on Face.

Indian dermatology online journal
2025

Facial follicular porokeratosis simulating discoid lupus erythematosus in an African American woman.

JAAD case reports
2025

Porokeratosis of Mibelli.

QJM : monthly journal of the Association of Physicians
2025

A rare case of mycosis fungoides with porokeratosis-like lesions: a case report and review of previous literature.

AME case reports
2025

Porokeratosis of Mibelli affecting the lips: A novel ultraviolet-induced fluorescence dermoscopy finding.

Photodiagnosis and photodynamic therapy
2025

Disseminated Superficial Actinic Porokeratosis in a Mother and Daughter: A Case Report.

Cureus
2025

Porokeratosis ptychotropica and concurrent condyloma acuminata respond well to photodynamic therapy.

Photodiagnosis and photodynamic therapy
2025

A New Case of Allergic Contact Dermatitis to Topical Simvastatin Used for Treatment of Porokeratosis.

Contact dermatitis
2025

Repurposing guselkumab to target itch in disseminated superficial actinic porokeratosis: insights from RNA sequencing.

Clinical and experimental dermatology
2025

A large pruritic plaque in a patient with 2 kidney transplants.

JAAD case reports
2025

UV-induced fluorescence dermatoscopy in a case of porokeratosis ptychotropica.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

Topical egg yolk oil (4% cholesterol) and oral rosuvastatin for the treatment of disseminated superficial actinic porokeratosis.

Indian journal of dermatology, venereology and leprology
2025

Porokeratosis Ptychotropica.

Journal of cutaneous medicine and surgery
2025

Rapid Progression of Linear Porokeratosis Following COVID-19 Vaccination: A Case Report.

Indian dermatology online journal
2025

Extensive Spiculated Follicular Porokeratosis With Alopecia: A Case Report.

Clinical case reports
2025

Genital porokeratosis: A case report and review of pathogenesis and genitogluteal subtypes of porokeratosis.

SAGE open medical case reports
2025

A Patient With Concurrent Hidradenitis Suppurativa and Porokeratosis Palmaris et Plantaris Disseminata: Case Report and Review of Autoinflammatory Keratinization Diseases.

Journal of cutaneous pathology
2024

Secrets of the Stratum Corneum I: Parakeratosis or Porokeratosis?

Skinmed
2024

Hereditary Spiny Keratoderma in a Pediatric Patient: A Case Report and Literature Review.

Cureus
2025

[Translated article] Wood's Light in Inflammatory and Autoimmune Dermatoses, Infections and Skin Cancer.

Actas dermo-sifiliograficas
2025

Porokeratosis ptychotropica: Case reports and literature review.

Annales de dermatologie et de venereologie
2024

Disseminated Superficial Actinic Porokeratosis Treated with Topical Simvastatin: Evaluation of Therapeutic Response with Dermoscopy.

Dermatology practical & conceptual
2024

Scalp Porokeratosis: Dermoscopy Key Role in Unmasking a Hidden Condition.

Dermatology practical & conceptual
2024

Disseminated Superficial Non-actinic Porokeratosis: A Consequence of Post-traumatic Immunosuppression.

Cureus
2025

Topical atorvastatin in the management of porokeratosis.

Indian journal of dermatology, venereology and leprology
2024

Porokeratoses-A Rare Group of Dermatoses.

Medicina (Kaunas, Lithuania)
2024

Disseminated superficial actinic porokeratosis in an elderly patient undergoing androgen deprivation therapy for advanced prostate cancer: exploring the potential association.

Dermatology reports
2024

Successful treatment of porokeratosis of Mibelli with pathogenesis-directed treatment of topical cholesterol-lovastatin.

Pediatric dermatology
2024

Disseminated superficial actinic porokeratosis treated with tretinoin and calcipotriene.

JAAD case reports
2025

Disseminated Superficial Actinic Porokeratosis: A Systematic Treatment Review.

American journal of clinical dermatology
2025

Lovastatin/cholesterol cream for the treatment of disseminated superficial actinic porokeratosis: a retrospective cohort study.

International journal of dermatology
2024

Penile and Scrotal Porokeratosis: A Single-Institution Experience.

The American Journal of dermatopathology
2024

Malignant Transformation in Porokeratosis Ptychotropica: A Systematic Review.

Acta dermato-venereologica
2025

[Translated article] RF- Relationship Between Porokeratosis and Skin Cancer.

Actas dermo-sifiliograficas
2025

Epidermal second-hit mutation in MVK gene associated with linear porokeratosis.

Genes & diseases
2024

Establishment of a Mouse Model for Porokeratosis Due to Mevalonate Diphosphate Decarboxylase Deficiency.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
2024

A Clinico-Epidemiological Study on Porokeratosis.

Indian journal of dermatology
2024

Porokeratosis of Mibelli Treated With Topical 2% Lovastatin/2% Cholesterol Ointment.

Cureus
2024

A case of porokeratosis with a variety of morphological manifestations.

Clinical case reports
2026

Porokeratosis ptychotropica without genitogluteal involvement - A rare presentation.

Indian journal of dermatology, venereology and leprology
2024

MVD Variants Identified in a Rare Clinical Variant of Porokeratosis: A Case Report of Disseminated Superficial Porokeratosis (DSP) in a Chinese Patient.

Clinical, cosmetic and investigational dermatology
2025

Porokeratoses: an update on pathogenesis and treatment.

International journal of dermatology
2024

Line-field confocal optical coherence tomography for the differential diagnosis of porokeratosis from clinical mimickers: a preliminary study.

Clinical and experimental dermatology
2024

Genitogluteal porokeratosis with dystrophic calcinosis on the scrotum.

Annales de dermatologie et de venereologie
2024

Presentations of Cutaneous Disease in Various Skin Pigmentations: Porokeratosis.

HCA healthcare journal of medicine
2024

Conventional and Novel Treatment Strategies for Porokeratoses: A Narrative Review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2025

Unilateral porokeratosis associated with neoadjuvant radiotherapy of the pelvis.

International journal of dermatology
2024

Porokeratosis on the lip: A Case Series.

Dermatology online journal
2024

Complete relief by omalizumab in eruptive pruritic papular porokeratosis.

JAAD case reports
2024

Disseminated superficial porokeratosis: two case reports of successful treatment with 2% crisaborole ointment.

International journal of dermatology
2024

Verrucous Linear Porokeratosis with Dermal Amyloid Deposits - A Rare Presentation.

Indian dermatology online journal
2024

A Case of Palmoplantar Porokeratosis With Hypokeratosis: A New Subtype of Porokeratosis?

The American Journal of dermatopathology
2024

A Case of Squamous Cell Carcinoma Arising in Disseminated Superficial Porokeratosis.

Clinical, cosmetic and investigational dermatology
2024

Porokeratosis Ptychotropica Mimicking Anogenital Warts.

Dermatology practical & conceptual
2024

Eruptive Pruritic Papular Porokeratosis (EPPP) Presenting as a Rare Facial Manifestation Associated With COVID-19: A Case Report.

Cureus
2024

Effective treatment of solar facial porokeratosis in one patient with topical atorvastatin/cholesterol cream.

Clinical and experimental dermatology
2024

Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis.

American journal of human genetics
2024

Successful treatment of porokeratosis ptychotropica with abrocitinib.

International journal of dermatology
2024

Accuracy of ultraviolet-induced fluorescence dermoscopy in porokeratosis: An observational study.

Journal of cosmetic dermatology
2024

Focal actinic porokeratosis over nose successfully treated with topical tacrolimus.

Indian journal of dermatology, venereology and leprology
2024

Spiny Keratoderma: Clinical and Histopathological Findings in a Series of 3 Cases.

The American Journal of dermatopathology
2024

Challenges in the Diagnosis and Management of Giant Porokeratosis: A Case Report.

Cureus
2024

Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments.

Nagoya journal of medical science
2024

An Unusual Clinical Presentation of Mibelli's Porokeratosis.

Skinmed
2024

Beyond the surface: Ultraviolet-induced fluorescence dermatoscopy in the diagnosis of segmental porokeratosis.

The Australasian journal of dermatology
2024

Blaschkoid disseminated superficial porokeratosis.

BMJ case reports
2024

Malignant transformation of porokeratosis of Mibelli in a psoriatic patient.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2023

Red Flat Papules on the Abdomen and Lower Limbs of an Old Woman.

Indian journal of dermatology
2024

A Rare Case of Follicular Porokeratosis Ptychotropica: When Dermoscopy Enghlitens Clinics.

Dermatology practical & conceptual
2025

Clinical-pathologic correlation: The impact of grossing at the bedside.

Seminars in diagnostic pathology
2024

[Translated article] Is Follicular Porokeratosis a Distinct Clinical Variant?

Actas dermo-sifiliograficas
2024

Disseminated Superficial Porokeratosis: A Case Report.

Cureus
2024

Mosaic GJB2 mutations in widespread porokeratotic adnexal ostial nevus: Report of two patients.

The Journal of dermatology
2024

Two Novel and Three Recurrent Mutations in the Mevalonate Pathway Genes in Chinese Patients with Porokeratosis.

Clinical, cosmetic and investigational dermatology
2023

Porokeratosis of the scrotum: a case report and literature review.

Frontiers in medicine
2024

Cutaneous Horn Presentation in Porokeratotic Eccrine Ostial and Dermal Duct Nevus. A Brief Review and Case Report.

The American Journal of dermatopathology
2023

Porokeratoses-A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants.

Metabolites
2024

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV
2023

Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications.

Clinical reviews in allergy & immunology
2023

Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis.

Journal of drugs in dermatology : JDD
2024

A novel homozygous variant in PMVK is associated with enhanced IL1β secretion and a hyper-IgD syndrome-like phenotype.

Clinical genetics
2024

Five years follow-up of a patient with porokeratosis ptychotropica and MVK gene mutation.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2023

Exclusive and Solitary Facial Porokeratosis: Pathogenesis and Literature Reappraisal of a Rare Entity.

Case reports in dermatology
2023

Possible Association of Interleukin-31/-31RA Signalling and Basophils with Itch in Porokeratosis.

Acta dermato-venereologica
2023

A Review of the Efficacy of Topical Statins for Treating Disseminated Superficial Actinic Porokeratosis.

Journal of drugs in dermatology : JDD
2024

Pathogenesis-directed treatment of linear porokeratosis with topical cholesterol-lovastatin.

Pediatric dermatology
2023

Bilateral Linear Porokeratosis Treated With Topical Lovastatin 2% Monotherapy.

Cureus
2023

A case of pruritic hyperkeratotic papules on the back.

JAAD case reports
2023

Clinicopathological retrospective analysis of porokeratosis ptychotropica and genitogluteal porokeratosis: confusion-prone but essentially different twins.

Archives of dermatological research
2023

Incidence and Prevalence of 73 Different Genodermatoses: A Nationwide Study in Sweden.

Acta dermato-venereologica
2023

A Report of Eruptive Pruritic Papular Porokeratosis Treated with Abrocitinib.

Clinical, cosmetic and investigational dermatology
2023

Characteristics of glioblastomas and immune microenvironment in a Chinese family with Lynch syndrome and concurrent porokeratosis.

Frontiers in oncology
2023

A Case of Linear Porokeratosis.

Indian dermatology online journal
2023

A Case of Disseminated Superficial Actinic Porokeratosis Successfully Treated With Topical Lovastatin/Cholesterol Gel.

Cureus
2023

Successful Treatment of Eruptive Pruritic Papular Porokeratosis in the Elderly with Tofacitinib: A Case Report.

Clinical, cosmetic and investigational dermatology
2023

Targeted anti-interleukin-17 therapy for linear porokeratosis.

The British journal of dermatology
2023

A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis.

Dermatology reports
2023

A Novel PMVK Variant Associated with Familial Porokeratosis.

Human heredity
2023

Combining Isotretinoin and Topical Cholesterol/Atorvastatin in the Treatment of Linear Porokeratosis: A Case Report.

Cureus
2023

Autosomal dominant genodermatoses in adults being heralded by superimposed skin lesions in children.

American journal of medical genetics. Part C, Seminars in medical genetics
2023

Case Report: A Novel MVK Missense Mutation in the Sporadic Porokeratosis Ptychotropica in China.

Clinical, cosmetic and investigational dermatology
2023

Decreased Imiquimod-Induced Psoriasis-Like Skin Inflammation in a Novel MvdF250S/+ Knock-In Mouse Model.

Inflammation
2023

Spiny Keratoderma in Association with Melanoma.

Dermatopathology (Basel, Switzerland)
2023

[Translated article] RF-Topical Cholesterol and Statin Formulation to Treat Porokeratosis.

Actas dermo-sifiliograficas
2024

Therapeutic Effects of Statins: Promising Drug for Topical and Transdermal Administration.

Current medicinal chemistry
2023

A rare case of punctate porokeratosis treated with topical lovastatin/cholesterol.

JAAD case reports
2023

Concomitance of Hidradenitis Suppurativa and Porokeratoses.

The Journal of clinical and aesthetic dermatology
2022

Porokeratosis Ptychotropica: A Rare Manifestation and Dermoscopic Feature.

Indian journal of dermatology
2023

Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.

JAMA dermatology
2023

Exclusive facial porokeratosis with follicular involvement in an African American female.

Journal of cutaneous pathology
2023

The Brownish Verrucous Plaques on Buttocks: Challenge.

The American Journal of dermatopathology
2023

The Brownish Verrucous Plaques on Buttocks: Answer.

The American Journal of dermatopathology
2023

Porokeratotic lichen planus of the lower extremities.

The Australasian journal of dermatology
2023

Differentiating Fordyce Spots from Their Common Simulators Using Ultraviolet-Induced Fluorescence Dermatoscopy-Retrospective Study.

Diagnostics (Basel, Switzerland)
2022

Dermoscopy of Zosteriform and Swirling Pattern Type 1 Segmental Darier Disease.

Acta dermatovenerologica Croatica : ADC
2023

Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin.

JAMA dermatology
2022

Treating linear porokeratosis with topical lovastatin/cholesterol cream.

Dermatology online journal
2022

A rare case of genital porokeratosis associated with epididymo-orchitis.

Indian journal of sexually transmitted diseases and AIDS
2023

Mosaic GJB2 mutation A88V leading to diffuse neonatal hyperkeratosis and porokeratotic hamartoma.

Journal of the European Academy of Dermatology and Venereology : JEADV
2023

Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations.

Clinical and experimental dermatology
2023

Histopathologic findings of drug-induced eruptive porokeratosis under nivolumab therapy.

Journal of cutaneous pathology
2023

A possible role for second-hit postzygotic GJB2 mutation in porokeratotic eccrine ostial and dermal duct nevus.

The Journal of dermatology
2022

Porokeratosis of gluteal region: A case report.

SAGE open medical case reports
2023

Porokeratosis ptychotropica: a case report.

Journal of Yeungnam medical science
2022

An unusual case report of porokeratosis ptychotropica on the buttocks.

Medicine
2022

Persistent plaque on the buttock of a 5-year-old girl.

Pediatric dermatology
2024

Perianal and Scrotal Porokeratosis Ptychotropica. Case Report of an Unusual Condition, and Review of the Literature.

Actas dermo-sifiliograficas
2022

Linear porokeratosis of the foot with dermoscopic manifestations: A case report.

World journal of clinical cases
2022

Porokeratosis and Lichen Planus: Co-Localisation or Isotopic Response or Koebner's Phenomenon?

Indian journal of dermatology
2023

A novel missense mutation in the MVK gene is associated with disseminated superficial porokeratosis.

International journal of dermatology
2023

Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report.

The Australasian journal of dermatology
2022

Porokeratotic Variant of Lichen Planus.

Skinmed
2022

A hidden and rare variant of porokeratosis: A case report of porokeratosis ptychotropica and report of the literature.

The Australasian journal of dermatology
2022

Plaque-type verrucous porokeratosis of the back.

JAAD case reports
2023

Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Palmar dermatofibroma in a patient with multiple porokeratosis.

Anais brasileiros de dermatologia
2022

Porokeratosis of Mibelli - Not So Rare in Coloured Skin.

Indian journal of dermatology
2023

Novel topical statin treatments of disseminated actinic porokeratosis risk provoking cutaneous sensitization.

Contact dermatitis
2022

Bilateral Linear Porokeratosis Treated With Topical Cholesterol 2%/Lovastatin 2.

Cureus
2022

Photodynamic therapy in pediatric age: Current applications and future trends.

Frontiers in pharmacology
2022

Assessing Cutaneous Mosaicism at the Molecular Level.

The Journal of investigative dermatology
2022

Disseminated Superficial Actinic Porokeratosis (DSAP): A Case Report Highlighting the Clinical, Dermatoscopic, and Pathology Features of the Condition.

Cureus
2022

Follicular Porokeratoma: Report of a New Variant of Porokeratoma (Porokeratotic Acanthoma) and Literature Review.

The American Journal of dermatopathology
2022

Effects of Blue Light on the Skin and Its Therapeutic Uses: Photodynamic Therapy and Beyond.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2022

Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders.

Pediatric dermatology
Ver todos os 1.202 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Poroqueratose.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Poroqueratose

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Systematized Linear Porokeratosis With Palmoplantar and Nail Involvement: A Rare Presentation.
    Cureus· 2026· PMID 41841075mais citado
  2. Successful Treatment of Linear Porokeratosis with Ivarmacitinib in an Adolescent: A Case Report.
    Clinical, cosmetic and investigational dermatology· 2026· PMID 41835962mais citado
  3. New Eruption of Bullous Pemphigoid Within Disseminated Superficial Porokeratosis Lesions: A Rare Case Report.
    The Australasian journal of dermatology· 2026· PMID 41787503mais citado
  4. Disseminated superficial porokeratosis with dermal amyloid deposits: A case report and review of the literature.
    The Journal of international medical research· 2026· PMID 41773530mais citado
  5. Identification of two novel MVD mutations and one novel FDPS mutation in Chinese patients with porokeratosis.
    Frontiers in medicine· 2026· PMID 41737384mais citado
  6. Solitary Porokeratoma on the Foot: A Case Report and Literature Review.
    Cureus· 2026· PMID 41994688recente
  7. Localized nasal porokeratosis successfully treated with 5-fluorouracil and calcipotriene.
    JAAD Case Rep· 2026· PMID 41993671recente
  8. Ultraviolet-Induced Fluorescence Dermatoscopy (UVFD) features in Porokeratosis: Findings from a Multicenter Retrospective Study.
    Dermatol Pract Concept· 2026· PMID 41912153recente
  9. Successful Treatment of Localized Eruptive Pruritic Papular Porokeratosis with A Single Session of Cryotherapy: A Case Report.
    Clin Cosmet Investig Dermatol· 2026· PMID 41909535recente
  10. Porokeratosis ptychotropica.
    Br J Dermatol· 2026· PMID 41906820recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79358(Orphanet)
  2. MONDO:0006602(MONDO)
  3. GARD:18989(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q7230264(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Poroqueratose
Compêndio · Raras BR

Poroqueratose

ORPHA:79358 · MONDO:0006602
CID-11
MedGen
UMLS
C0162839
Repurposing
3 candidatos
ingenolPKC activator
retinolretinoid receptor ligand
ureahydroxy radical formation stimulant
EuropePMC
Wikidata
Papers 10a
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades